- Report
- January 2026
- 185 Pages
Global
From €4020EUR$4,500USD£3,438GBP
- Report
- May 2026
- 185 Pages
Global
From €4020EUR$4,500USD£3,438GBP
- Report
- March 2026
- 250 Pages
Global
From €4011EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €4011EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €4011EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €4011EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €4011EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €4011EUR$4,490USD£3,430GBP
- Report
- February 2026
- 250 Pages
Global
From €4011EUR$4,490USD£3,430GBP
- Report
- August 2026
- 390 Pages
Global
From €5226EUR$5,850USD£4,469GBP
- Report
- August 2026
- 173 Pages
Global
From €5226EUR$5,850USD£4,469GBP
- Report
- August 2026
- 312 Pages
Global
From €5226EUR$5,850USD£4,469GBP
- Report
- August 2026
- 132 Pages
Global
From €4243EUR$4,750USD£3,629GBP
- Report
- April 2026
- 180 Pages
Global
From €4243EUR$4,750USD£3,629GBP
- Report
- July 2026
- 160 Pages
Global
From €2966EUR$3,320USD£2,536GBP
€3707EUR$4,150USD£3,171GBP
- Report
- April 2026
- 160 Pages
Global
From €2966EUR$3,320USD£2,536GBP
€3707EUR$4,150USD£3,171GBP
- Report
- October 2025
- 160 Pages
Global
From €2823EUR$3,160USD£2,414GBP
€3529EUR$3,950USD£3,018GBP
- Report
- April 2026
- 128 Pages
Global
From €3500EUR$4,197USD£3,098GBP
- Report
- February 2026
- 127 Pages
Global
From €3500EUR$4,197USD£3,098GBP
- Report
- November 2025
- 150 Pages
Global
From €4333EUR$4,850USD£3,705GBP

Hemostasis is a process that helps to stop bleeding and is a part of the larger coagulation and hemostasis testing market. This market includes products and services used to diagnose and monitor bleeding and clotting disorders. Tests used in this market include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen, and platelet aggregation. These tests are used to diagnose and monitor conditions such as hemophilia, thrombocytopenia, and von Willebrand disease.
The coagulation and hemostasis testing market is driven by the increasing prevalence of bleeding and clotting disorders, the growing demand for point-of-care testing, and the development of new technologies. Companies in this market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Alere Inc. Show Less Read more